Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-11-000733
Filing Date
2011-11-17
Accepted
2011-11-17 16:03:15
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 390038
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 10668
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 10868
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5671
  Complete submission text file 0001255294-11-000733.txt   1717425

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ambs-20110930.xml EX-101.INS 251864
6 XBRL SCHEMA FILE ambs-20110930.xsd EX-101.SCH 12503
7 XBRL DEFINITION FILE ambs-20110930_def.xml EX-101.DEF 7489
8 XBRL LABEL FILE ambs-20110930_lab.xml EX-101.LAB 76455
9 XBRL PRESENTATION FILE ambs-20110930_pre.xml EX-101.PRE 58336
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus BioSciences, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-148922 | Film No.: 111213120
SIC: 2834 Pharmaceutical Preparations